-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PrmGH9Ch6KIuPDNhgdRjRAVTPmHEkJKLegCmWYxilK3X0Y+uRhxgIQNltqSEzAvA P3PjdF2vxDFV/YXJBq99EA== 0001179110-04-008957.txt : 20040428 0001179110-04-008957.hdr.sgml : 20040428 20040428083506 ACCESSION NUMBER: 0001179110-04-008957 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040311 FILED AS OF DATE: 20040428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 021942725 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WARD J BARRIE CENTRAL INDEX KEY: 0001255637 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 04758581 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVENUE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVENUE CITY: NEEDHAM STATE: MA ZIP: 02494 4/A 1 edgar.xml FORM 4/A - X0202 4/A 2004-03-11 2004-03-12 0 0000744218 AVANT IMMUNOTHERAPEUTICS INC AVAN 0001255637 WARD J BARRIE 119 FOURTH AVENUE NEEDHAM MA 024954 1 0 0 0 Common Stock 2004-03-11 4 M 0 332141 0.64 A 367915 D Incentive Stock Option 0.64 2004-03-11 4 M 0 332141 0.64 D 1998-07-11 2004-07-11 Common Stock 332141 118833 D J. Barrie Ward 2004-03-12 EX-24 2 ex24jbward2.txt LIMITED POWER OF ATTORNEY FOR AVANT IMMUNOTHERAPEUTICS, INC. SECTION 16(a) FILINGS Know all men by these presents, that the undersigned hereby constitutes and appoints each of Avery W. Catlin and Una S. Ryan, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or stockholder of AVANT Immunotherapeutics, Inc. (the "Company"), Forms 3, 4, and 5 and any amendments thereto in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 or amendment thereto and timely file such form with the United States Securities and Exchange Commission (the "SEC") and any stock exchange or similar authority; and (3) take any other action of any type whatsoever which, in the opinion of such attorney-in- fact, may be necessary or desirable in connection with the foregoing authority, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney may be filed with the SEC as a confirming statement of the authority granted herein. IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of this 16th day of March, 2004. /s/ J. Barrie Ward Signature J. Barrie Ward Print Name -----END PRIVACY-ENHANCED MESSAGE-----